Page 30 - The Indian Optician Digital Edition March-April 2021
P. 30

BAUSCH + LOMB                                  J&J VISION’S ACUVUE
          INTRODUCES                             THERAVISION APPROVED FOR

          ULTRA                                            ALLERGIC EYE ITCH
          MULTIFOCAL
          FOR                                       The Japanese Ministry of Health, Labour and Welfare

          ASTIGMATISM                            (MHLW) has given its approval to Johnson & Johnson’s
                                                 Acuvue Theravision with Ketotifen for allergic eye itch.

                                                    According to a press release issued by the company,
                                                 “This Acuvue lens is “the first and only vision correction
                                                 contact lens that relieves allergic eye itch.” The lens
                                                 contains ketotifen, an H1 histamine receptor antagonist
                                                 for the prevention of itch associated with eye allergies.

                                                    The release further states that this is the first regulatory
                                                 approval by any health authority for the novel technology,
             Bausch + Lomb has                   which combines an Acuvue daily disposable contact lens
          added to its Ultra monthly             (etafilcon A) with ketotifen, an established antihistamine.
          reusable contact lens family
          by releasing its new ULTRA                “This approval marks another significant milestone in
                                     ®
          Multifocal for Astigmatism             Johnson & Johnson Vision’s legacy of rethinking what’s
          which incorporates Moisture            possible with contact lenses, and bringing forward
              ®
          Seal  Technology while                 innovations to help eyecare practitioners better meet the
          combining the 3-Zone                   needs of their patients around the world,” said Xiao-Yu
          Progressive Design™ and                Song, MD, PhD, global head of research & development,
          OpticAlign™ Design, to meet
          the needs of astigmatic                Johnson & Johnson Vision. “Our goal at Johnson &
          presbyopic patients.                   Johnson Vision is to change the trajectory of eye health
                                                 and we will continue to drive new innovation and
             Bausch + Lomb ULTRA                 technologies that correct, enhance, and restore people’s
          Multifocal for Astigmatism             vision over their lifetimes.”
          contact lenses with
                       ®
          MoistureSeal  technology help             Itchy allergy eyes can adversely affect vision and
          prevent lens dehydration that          creates problems for contact lens wearers—most of whom
          may be caused by reduced               resort to rubbing their eyes. J&J Vision data shows that 8
          blink rates and retain moisture        out of 10 contact lens wearers feel frustrated when their
          for a full 16 hours. They also         eye allergies interfere with normal contact lens wear.
          provide superior end-of-day
          vision for digital device users           Acuvue Theravision with Ketotifen may help patients
          and correct near or distance           who wish to continue wearing contact lenses during
          vision, astigmatism and                the allergy season. However, at present, the lens is not
          presbyopia all in one.                 approved for the U.S. market.
                                                  pp
             The 3-Zone Progressive™
          Design ensures stable,
          seamless vision for near, far
          and in-between while the
          OpticAlign™ Design allows ≤5˚
          rotation on 95% of patients.
             The lenses are easy to fit
          but are presently available for
          the UK market only.


           |  MAR-APR 2021  |  26  CONTACT LENS NEWS






   Mar-Apr 2021 SK News.indd   6                                                                             27-04-2021   15:43
   25   26   27   28   29   30   31   32   33   34   35